P.J. Cimino

National Institutes of Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Frank Szulzewsky

Assistant Professor

University of Utah Health Huntsman Cancer Institute

UNITED STATES

View details

Taran Gujral

Associate Professor

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Sandra Camelopiragua

University of Michigan

UNITED STATES

View details

Keith Loeb

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Christopher Keene

Associate Professor

University of Washington

UNITED STATES

View details

Sonali Arora

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Osorio Lopes Abath Neto

Clinical Assistant Professor

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Siobhan Pattwell

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Michael Zager

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Eric J. Duncavage

Washington University School of Medicine

UNITED STATES

View details

Felix Sahm

University Hospital Heidelberg

GERMANY

View details

Jeffrey Nirschl

Assistant Professor

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

P.J. Cimino

Research Interests

Explore related searches

Contact this professor

Articles (10)

Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1

Whole gain of chromosome 19, not co-gain of chromosomes 19 and 20, characterizes a class of glioblastomas with more favorable outcomes

Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype

Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2

Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice

Oncogenic role of a developmentally regulated NTRK2 splice variant

Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.

A single-cell based precision medicine approach using glioblastoma patient-specific models

Recurrent switch 2 domain <i>RAC2</i> mutations in intravascular large B-cell lymphoma

Neuropathologic features of central nervous system hemangioblastoma.

Collaborators (12)

Frank Szulzewsky

Taran Gujral

Sandra Camelopiragua

Keith Loeb

Christopher Keene

Sonali Arora

Osorio Lopes Abath Neto

Siobhan Pattwell

Michael Zager

Eric J. Duncavage

Felix Sahm

Jeffrey Nirschl

Make your next move.